Related Experiment Video
Updated: Jun 9, 2026
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Selective cell death mediated by small conditional RNAs
Suvir Venkataraman1, Robert M Dirks, Christine T Ueda
1Department of Bioengineering, California Institute of Technology, Pasadena, CA 91125, USA.
Abstract:
Cancer cells are characterized by genetic mutations that deregulate cell proliferation and suppress cell death. To arrest the uncontrolled replication of malignant cells, conventional chemotherapies systemically disrupt cell division, causing diverse and often severe side effects as a result of collateral damage to normal cells. Seeking to address this shortcoming, we pursue therapeutic regulation that is conditional, activating selectively in cancer cells. This functionality is achieved using small conditional RNAs that interact and change conformation to mechanically transduce between detection of a cancer mutation and activation of a therapeutic pathway. Here, we describe small conditional RNAs that undergo hybridization chain reactions (HCR) to induce cell death via an innate immune response if and only if a cognate mRNA cancer marker is detected within a cell. The sequences of the small conditional RNAs can be designed to accept different mRNA markers as inputs to HCR transduction, providing a programmable framework for selective killing of diverse cancer cells. In cultured human cancer cells (glioblastoma, prostate carcinoma, Ewing's sarcoma), HCR transduction mediates cell death with striking efficacy and selectivity, yielding a 20- to 100-fold reduction in population for cells containing a cognate marker, and no measurable reduction otherwise. Our results indicate that programmable mechanical transduction with small conditional RNAs represents a fundamental principle for exploring therapeutic conditional regulation in living cells.
Insights
New RNA technology selectively targets cancer cells for destruction. This programmable system uses hybridization chain reactions (HCR) to activate cell death only when specific cancer markers are detected, minimizing harm to healthy cells.
Area of Science:
- Biotechnology
- Molecular Biology
- Oncology
Background:
- Cancer cells exhibit genetic mutations causing uncontrolled proliferation and resistance to cell death.
- Conventional chemotherapy causes severe side effects due to collateral damage to normal cells.
- There is a need for targeted cancer therapies that activate selectively within malignant cells.
Purpose of the Study:
- To develop a novel therapeutic strategy for cancer treatment using small conditional RNAs.
- To engineer a programmable system for selective cancer cell death.
- To investigate the potential of mechanical transduction for conditional therapeutic regulation.
Main Methods:
- Designed small conditional RNAs capable of undergoing hybridization chain reactions (HCR).
- Engineered RNAs to mechanically transduce signals from cancer-specific mRNA markers to therapeutic pathway activation.
- Tested the efficacy and selectivity of HCR-mediated cell death in cultured human cancer cells (glioblastoma, prostate carcinoma, Ewing's sarcoma).
Main Results:
- HCR transduction effectively induced cell death specifically in cancer cells harboring cognate mRNA markers.
- Achieved a 20- to 100-fold reduction in cancer cell populations with no measurable reduction in non-cancerous cells.
- Demonstrated the programmable nature of the system by designing RNAs responsive to different mRNA markers.
Conclusions:
- Programmable mechanical transduction with small conditional RNAs offers a highly selective and effective approach for cancer therapy.
- This technology minimizes collateral damage to healthy tissues, addressing a key limitation of current chemotherapies.
- The findings establish a fundamental principle for conditional therapeutic regulation in living cells.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Related Concept Videos
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:17The Extrinsic Apoptotic Pathway
01:22MicroRNAs